Pneumocystis Jirovecii Pneumonia (PCP): Diagnosis and Management
Element | Comment |
---|---|
Patients at risk | Newly diagnosed HIV infection with advanced disease (CD4 count <200) Patients with previous PCP or CD4 count <200 who are not taking prophylaxis |
Clinical features | Subacute onset Fever (∼90%) Cough (∼95%), usually non-productive Progressive breathlessness (∼95%) Tachypnoea (∼60%) Chest examination normal in ∼50% |
Chest X-ray features | Initially normal in up to 25% Commonest abnormalities are diffuse bilateral interstitial or alveolar shadowing Lobar consolidation rare. Pleural effusion rare. Pneumothorax may occur |
Induced sputum | Staining of induced sputum for P. jirovecii trophic forms and cysts Specificity ∼100%, sensitivity 5090% PCR Sensitivity 98%, specificity 8098% |
Bronchoscopy with bronchoalveolar lavage | Indicated if PCP is suspected but induced sputum is non-diagnostic or cannot be done Specificity ∼100%, sensitivity ∼8090% |
Antimicrobial therapy | First choice: co-trimoxazole PO or IV for 21 days. Causes haemolysis in glucose-6-phosphate dehydrogenase-deficient patients (African/Mediterranean). Other side effects include nausea, vomiting, fever, rash, marrow suppression and raised transaminases. Alternative regimens: primaquine + clindamycin; atovaquone; pentamidine |
Adjuvant steroid therapy | Start immediately if severe PCP (breathless at rest; PaO2 breathing air <8 kPa; extensive interstitial shadowing on chest X-ray) Give prednisolone 40 mg twice daily PO for 5 days, followed by prednisolone 40 mg daily PO for 5 days, then prednisolone 20 mg daily PO for 11 days |